During the past decade, Urology Consultants, P.A. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Urology Consultants, P.A." are "Benign Prostatic Hypertrophy" (1 trials), "Prostate Cancer" (1 trials), "Prostatic Hyperplasia" (1 trials) and "Urinary Retention" (1 trials). Many other conditions were trialed in "Urology Consultants, P.A." in a lesser frequency.

Most popular intervention types in "Urology Consultants, P.A." are "Drug" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alfuzosin (SL770499)" (1 trials), "adjuvant therapy" (1 trials) and "tarenflurbil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urology Consultants, P.A." are 2 trials for "Male" genders.

Currently, there are NaN active trials in "Urology Consultants, P.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Urology Consultants, P.A., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Urology Consultants, P.A., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".